Literature DB >> 34741637

Individualised screening of diabetic foot: creation of a prediction model based on penalised regression and assessment of theoretical efficacy.

Iztok Štotl1, Rok Blagus2,3, Vilma Urbančič-Rovan4,5.   

Abstract

AIMS/HYPOTHESIS: A large proportion of people with diabetes do not receive proper foot screening due to insufficiencies in healthcare systems. Introducing an effective risk prediction model into the screening protocol would potentially reduce the required screening frequency for those considered at low risk for diabetic foot complications. The main aim of the study was to investigate the value of individualised risk assignment for foot complications for optimisation of screening.
METHODS: From 2015 to 2020, 11,878 routine follow-up foot investigations were performed in the tertiary diabetes clinic. From these, 4282 screening investigations with complete data containing all of 18 designated variables collected at regular clinical and foot screening visits were selected for the study sample. Penalised logistic regression models for the prediction of loss of protective sensation (LOPS) and loss of peripheral pulses (LPP) were developed and evaluated.
RESULTS: Using leave-one-out cross validation (LOOCV), the penalised regression model showed an AUC of 0.84 (95% CI 0.82, 0.85) for prediction of LOPS and 0.80 (95% CI 0.78, 0.83) for prediction of LPP. Calibration analysis (based on LOOCV) presented consistent recall of probabilities, with a Brier score of 0.08 (intercept 0.01 [95% CI -0.09, 0.12], slope 1.00 [95% CI 0.92, 1.09]) for LOPS and a Brier score of 0.05 (intercept 0.01 [95% CI -0.12, 0.14], slope 1.09 [95% CI 0.95, 1.22]) for LPP. In a hypothetical follow-up period of 2 years, the regular screening interval was increased from 1 year to 2 years for individuals at low risk. In individuals with an International Working Group on the Diabetic Foot (IWGDF) risk 0, we could show a 40.5% reduction in the absolute number of screening examinations (3614 instead of 6074 screenings) when a 10% risk cut-off was used and a 26.5% reduction (4463 instead of 6074 screenings) when the risk cut-off was set to 5%. CONCLUSIONS/
INTERPRETATION: Enhancement of the protocol for diabetic foot screening by inclusion of a prediction model allows differentiation of individuals with diabetes based on the likelihood of complications. This could potentially reduce the number of screenings needed in those considered at low risk of diabetic foot complications. The proposed model requires further refinement and external validation, but it shows the potential for improving compliance with screening guidelines.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Diabetes; Diabetic foot; Neuropathy; Penalised regression; Peripheral artery disease; Screening

Mesh:

Year:  2021        PMID: 34741637     DOI: 10.1007/s00125-021-05604-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Screening interval: a public health blind spot.

Authors:  Arnaud Chiolero; Daniela Anker
Journal:  Lancet Public Health       Date:  2019-04

2.  Validation of clinical prediction models: what does the "calibration slope" really measure?

Authors:  Richard J Stevens; Katrina K Poppe
Journal:  J Clin Epidemiol       Date:  2019-10-09       Impact factor: 6.437

3.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

Review 4.  The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus.

Authors:  Yuzhe Feng; Felix J Schlösser; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2010-08-08       Impact factor: 4.268

5.  Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial.

Authors:  D K Litzelman; C W Slemenda; C D Langefeld; L M Hays; M A Welch; D E Bild; E S Ford; F Vinicor
Journal:  Ann Intern Med       Date:  1993-07-01       Impact factor: 25.391

6.  Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update).

Authors:  Sicco A Bus; Lawrence A Lavery; Matilde Monteiro-Soares; Anne Rasmussen; Anita Raspovic; Isabel C N Sacco; Jaap J van Netten
Journal:  Diabetes Metab Res Rev       Date:  2020-03       Impact factor: 4.876

Review 7.  Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review.

Authors:  Kristien van Acker; Philippe Léger; Agnes Hartemann; Abhineet Chawla; Mohd Kashif Siddiqui
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

Review 8.  Modelling the prevalence of diabetes mellitus risk factors based on artificial neural network and multiple regression.

Authors:  Kamal Gholipour; Mohammad Asghari-Jafarabadi; Shabnam Iezadi; Ali Jannati; Sina Keshavarz
Journal:  East Mediterr Health J       Date:  2018-10-10       Impact factor: 1.628

9.  Diabetic foot screening: study of a 3000 times cheaper instrument.

Authors:  Maria Candida Ribeiro Parisi; Daniel Giannella; Tulio Diniz Fernandes; Karla Freire Rezende; Marcia Nery
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  A comparison of penalised regression methods for informing the selection of predictive markers.

Authors:  Christopher J Greenwood; George J Youssef; Primrose Letcher; Jacqui A Macdonald; Lauryn J Hagg; Ann Sanson; Jenn Mcintosh; Delyse M Hutchinson; John W Toumbourou; Matthew Fuller-Tyszkiewicz; Craig A Olsson
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.